Legend Biotech (LEGN) Operating Income Growth (3y) (2025 - 2026)

Legend Biotech (LEGN) Operating Income Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn - 16.96%
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.75 Bn 467.96 Bn 1.35 Bn 38.78%
5 Vertex Pharmaceuticals 122.14 Bn 114.89 Bn 2.59 Bn 13.47%
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn -12.10%
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn 69.02%
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 55.96%
10 Legend Biotech 7.12 Bn 6.48 Bn 129.70 Mn -35.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.03%
Dec 31, 2025 -29.58%
Sep 30, 2025 -32.67%